SCHEMBL11999050

SCHEMBL11999050

CNC(=O)C1=CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24727543 0.91 GAA (0.34)
SCHEMBL18773189 0.82 HDAC2 (0.31)
SCHEMBL14448972 0.82
SCHEMBL18909066 0.81 HDAC2 (0.32)
SCHEMBL24170477 0.80
SCHEMBL12247919 0.77 EPHX2 (0.45)
SCHEMBL27285473 0.75 TSHR (0.31)
SCHEMBL15321216 0.75
SCHEMBL24997849 0.75
SCHEMBL24998751 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159446-A1 Methods and Compositions for Targeting Tregs using CCR8 Inhibitors NANJING IMMUNOPHAGE BIOMEDICAL CO., LTD. (CN) 2023-05-25 US disclosed
WO-2022000443-A1 METHODS AND COMPOSITIONS FOR TARGETING TREGS USING CCR8 INHIBITORS Nanjing Immunophage Biotech Co., Ltd. (CN) 2022-01-06 WO disclosed
EP-0862464-B1 AMINO ACID ANALOGS FOR TUMOR IMAGING UNIV EMORY (US) 2012-08-22 EP disclosed
US-7989649-B2 Tumor imaging compounds EMORY UNIVERSITY (US) 2011-08-02 US disclosed
US-7989649-B2 Tumor imaging compounds EMORY UNIVERSITY (US) 2011-08-02 US disclosed
US-20090240041-A1 TUMOR IMAGING COMPOUNDS EMORY UNIVERSITY (US) 2009-09-24 US disclosed
US-20090240041-A1 TUMOR IMAGING COMPOUNDS EMORY UNIVERSITY (US) 2009-09-24 US disclosed
US-7544715-B2 Tumor imaging compounds EMORY UNIVERSITY (US) 2009-06-09 US disclosed
US-7544715-B2 Tumor imaging compounds EMORY UNIVERSITY (US) 2009-06-09 US disclosed